Identification of ALK Gene Alterations in Urothelial Carcinoma

• Joaquim Bellmunt ,

  * E-mail: joaquim_bellmunt@dfci.harvard.edu

  Affiliations Bladder Cancer Center, Dana-Farber Cancer Institute/Harvard Medical School, Boston, Massachusetts, United States of America, Hospital del Mar Research Institute-IMIM, Barcelona, Spain

  ⨯
• Shamini Selvarajah,

  Affiliation Bladder Cancer Center, Dana-Farber Cancer Institute/Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Scott Rodig,

  Affiliation Bladder Cancer Center, Dana-Farber Cancer Institute/Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Marta Salido,

  Affiliation Department of Pathology, Hospital del Mar Research Institute-IMIM, Barcelona, Spain

  ⨯
• Silvia de Muga,

  Affiliation Department of Pathology, Hospital del Mar Research Institute-IMIM, Barcelona, Spain

  ⨯
• Irmgard Costa,

  Affiliation Hospital Parc Tauli, Sabadell, Spain

  ⨯
• Beatriz Bellosillo,

  Affiliation Department of Pathology, Hospital del Mar Research Institute-IMIM, Barcelona, Spain

  ⨯
• Lillian Werner,

  Affiliation Biostatistics and Computational Biology, Harvard Medical School, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America

  ⨯
• Stephanie Mullane,

  Affiliation Bladder Cancer Center, Dana-Farber Cancer Institute/Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• André P. Fay,

  Affiliation Bladder Cancer Center, Dana-Farber Cancer Institute/Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Robert O'Brien,

  Affiliation Bladder Cancer Center, Dana-Farber Cancer Institute/Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Jordi Barretina,

  Affiliation Broad Institute, Cambridge, Massachusetts, United States of America

  ⨯
• André E. Minoche,

  Affiliations Max Planck Institute for Molecular Genetics, Berlin, Germany, Centre for Genomic Regulation (CRG), Barcelona, Spain, Universitat Pompeu Fabra, Barcelona, Spain

  ⨯
• Sabina Signoretti,

  Affiliation Bladder Cancer Center, Dana-Farber Cancer Institute/Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Clara Montagut,

  Affiliation Hospital del Mar Research Institute-IMIM, Barcelona, Spain

  ⨯
• Heinz Himmelbauer,

  Affiliations Centre for Genomic Regulation (CRG), Barcelona, Spain, Universitat Pompeu Fabra, Barcelona, Spain

  ⨯
• David M. Berman,

  Affiliation Department of Pathology, Johns Hopkins University, Baltimore, Maryland, United States of America

  ⨯
• Philip Kantoff,

  Affiliation Bladder Cancer Center, Dana-Farber Cancer Institute/Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Toni K. Choueiri,

  Affiliation Bladder Cancer Center, Dana-Farber Cancer Institute/Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
•  [ ... ],
• Jonathan E. Rosenberg

  Affiliation Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

  ⨯
• [ view all ]
• [ view less ]